Streetbeat News

Stock Prices

BALY

CZR

LVS

MGM

WYNN

MGM Resorts International's chances of winning two of the three full-scale casino licenses in New York City have reportedly become complicated due to an alleged bookmaking scandal in Las Vegas. The scandal involves the former head of the MGM Grand casino in Las Vegas, Scott Sibella, who was made to step down as president and operating chief of Resorts World. This could potentially benefit MGM's rivals in the casino race, including Bally's Corp, Caesars Entertainment Inc, Las Vegas Sands Corp, and Wynn Resorts Limited.

Portfolio Pulse from Shivani Kumaresan

September 19, 2023 | 12:13 pm

BIOR

Biora Therapeutics, Inc. (NASDAQ:BIOR) has entered into a $50 million equity swap agreement with Athyrium Capital Management. The deal involves exchanging senior convertible notes due 2025 for a combination of common stock and pre-funded warrants. The exchange price is $3.01 per share, a 44% premium to the closing price on September 18, 2023.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2023 | 12:09 pm

ELOX

Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) has announced a registered direct offering of 380,590 shares at $5.255 per share, expected to raise approximately $2 million. The company also plans to issue unregistered warrants to purchase an equivalent number of shares at $5.13 per share. The proceeds will be used to advance various projects, including the development of ELX-02 for the treatment of Alport syndrome and other rare kidney diseases.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2023 | 12:09 pm

SGBX

Safe & Green Holdings Corp. (NASDAQ:SGBX) has announced the distribution date of September 27, 2023, for the planned spin-off of its real estate development subsidiary, Safe & Green Development Corp (SG DevCo). Approximately 30% of the outstanding shares of SG DevCo common stock will be distributed to SG Holdings' stockholders on a pro rata basis. The company expects commencement of trading on the Nasdaq Stock Market on September 19, 2023, under the ticker symbol 'SGDVV'.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2023 | 12:01 pm

DE

Over the past 3 months, 12 analysts have published their opinion on Deere (NYSE:DE) stock. The company has an average price target of $457.25, an increase of 1.81% from the previous average price target of $449.10. The analysts' ratings range from bullish to indifferent, with no bearish ratings.

Portfolio Pulse from Benzinga Insights

September 19, 2023 | 12:01 pm

SMCI

Super Micro Computer (NASDAQ:SMCI) has received various analyst ratings in the last quarter, with 4 bullish, 2 somewhat bullish, and 2 indifferent. The average price target is $343.38, indicating an upside from the current price of $244.3. This average price target has increased by 35.32% over the past month.

Portfolio Pulse from Benzinga Insights

September 19, 2023 | 12:01 pm

SHOO

In the last quarter, Steven Madden (NASDAQ:SHOO) received 4 bullish and 2 indifferent analyst ratings. The average 12-month price target for the company, according to 6 analysts, is $39.83, a decrease of 3.63% from the previous average of $41.33.

Portfolio Pulse from Benzinga Insights

September 19, 2023 | 12:01 pm

SPSC

In the last quarter, SPS Commerce (NASDAQ:SPSC) has received 6 bullish ratings and 1 indifferent rating from analysts. The average 12-month price target for the company has increased by 24.3% to $199.29, with a high of $205.00 and a low of $175.00.

Portfolio Pulse from Benzinga Insights

September 19, 2023 | 12:00 pm

FORM

FormFactor (NASDAQ:FORM) has received 4 bullish and 2 indifferent analyst ratings in the last quarter, with an average price target of $40.17, indicating an upside from the current price of $33.11. The average price target has increased by 13.15% over the past month.

Portfolio Pulse from Benzinga Insights

September 19, 2023 | 12:00 pm

ACON

AVGR

BETS

CATX

CNXA

CYBN

DTOC

ELUT

FLJ

GRTX

LIFW

LLAP

NEPT

NVOS

RKLB

SLQT

SNTI

SXTP

TTOO

WORX

Shares of several companies including Connexa Sports Technologies, Elutia, Galera Therapeutics, Senti Biosciences, Neptune Wellness Solutions, Aclarion, Cybin, Avinger, SelectQuote, and Bit Brother Limited are trading higher in pre-market. Elutia's shares rose after the sale of its Orthobiologics business unit to Berkeley Biologics. Galera scheduled a meeting with the FDA to discuss next steps for its radiotherapy avasopasem. Neptune Wellness announced intention to spinout Sprout Organics. Cybin shares surged after hedge fund owner Steve Cohen invested $19 million in the company. On the other hand, shares of Digital Transformation Opportunities Corp., Rocket Lab USA, Novo Integrated Sciences, 60 Degrees Pharmaceuticals, Terran Orbital Corporation, Perspective Therapeutics, MSP Recovery, T2 Biosystems, SCWorx Corp., and FLJ Group Limited are trading lower in pre-market.

Portfolio Pulse from Lisa Levin

September 19, 2023 | 11:59 am